Introduction
Computational methods used in vaccine design have been changing drastically in recent years. In classical immunological research results could be recorded by pen and pencil or in a spreadsheet, but new experimental highthroughput methods such as sequencing, DNA arrays, and proteomics have generated a wealth of data that are not efficiently handled and mined by these approaches. This has fueled the rapid growth of the field of Immunological Bioinformatics (or Immuno-informatics) that addresses how to handle these large amounts of data in the field of immunology and vaccine design. Many of the methods have been made available on the Internet and can be used by experimental researchers without expert knowledge of bioinformatics. This review attempts to give an overview over the methods currently available and to point out the strengths and weaknesses of the different methods.
Immunological processes described by prediction servers
Only a small fraction of the possible peptides that can be generated from proteins of pathogenic organisms actually generate an immune response. In order to be presented to CD8+ T cells a precursor peptide must be generated by the proteasome. This peptide may be trimmed at the N-terminal by other peptidases in the cytosol (Levy et al., 2002) . It must then bind to the transporter associated with antigen processing (TAP) in order to be translocated to the endoplasmatic reticulum (ER). Here it can be trimmed N-terminally by the aminopeptidase associated with antigen processing (ERAAP) while it binds to the major histocompatibility complex class I (MHC I) molecule (Serwold, 2002) . Hereafter it is transported to the cell surface. Only half the peptides presented on the cell surface are immunogenic probably due to the limited size of the T cell receptor (TCR) repertoire. The most selective step is binding to the MHC I molecule, since only 1/200 binds with an affinity strong enough to generate an immune response (Yewdell, 1999) . For comparison the selectivity of TAP binding is reported to be 1/7 (Uebel et al., 1997) . This all happens in competition with other peptides so in order for a peptide to be immunogenic (immunodominant) it must go through the above described process more efficiently than other peptides produced in a given cell (Reviewed by Yewdell, 1999) .
Whereas the MHC I molecule mainly samples peptides from the cytosol, the MHC II molecule presents peptides from endocytosed proteins. Unfolded polypeptides bind to MHC II in the endocytic organelles (Reviewed by Castllino, 1997) . Both MHC I and MHC II are highly polymorphic, and the specificity of the alleles are often very different. Different individuals will thus typically react to a different set of peptides from a pathogen.
The specificity of some of the processes involved in antigen presentation can be predicted from the amino acid sequence. This can for example be used to select epitopes for use in a vaccine, and help to understand the role of the immune system in infectious diseases, autoimmune diseases and cancers. Below we describe a number of resources available on the web that can perform such predictions.
Databases of MHC binding peptides
Several databases of MHC binding peptides now exist on the web (Table 1). SYFPEITHI: The SYFPEITHI database contains information on peptide sequences, anchor positions, MHC specificity, source proteins, source organisms, and publication references. The database comprise approximately 3500 peptide sequences known to bind class I and class II MHC molecules and is based on previous publications on T-cell epitopes and MHC ligands from many species (Rammensee, 1999) . MHCPEP: The other major database of MHC binding peptides, MHCPEP, (Brusic, 1997) comprises over 13,000 peptide sequences known to bind MHC molecules. Entries were compiled from published reports as well as from direct submissions of experimental data. Each entry contains the peptide sequence, its MHC specificity and, when available, experimental method, observed activity, binding affinity, source protein, anchor positions, and publication references. Unfortunately the database has since June 1998 been static. The database can be downloaded as an ASCII file. JenPep: The JenPep database is a newer database that contains quantitative binding data of peptides to MHC and TAP, as well as T cell epitopes (Blythe, 2001) . The database contains more than 8000 entries . (Korber et al., 2001) . EPIMHC: MHC ligand database that can be searched based on sequence, length, class, species, and on whether a ligand is an epitope or not.
NIH will over the next five to seven years fund an "Immune Epitope Database and Analysis Program" (www.niaid.nih.gov/contract/archive/ rfp0331.pdf) to design, develop, populate, and maintain a publicly accessible, comprehensive Immune Epitope Database containing linear and conformational antibody epitopes and T cell epitopes. This database may eventually incorporate most of the data from the above described databases.
Prediction of MHC binding
Several peptide-MHC binding prediction servers exist on the web (Table 2). As indicated in the table some of the web based methods also allow prediction of binding to Class II molecules. Most methods available on the web for predicting MHC-peptide binding are matrix methods. Parameters are often derived from pool sequencing of ligands. Matrices or hidden Markov models may however also be derived from a set of ligand sequences. In these methods the amino acid on each position in the motif gives an independent contribution to the prediction score. Neural networks are able to make more accurate predictions if correlations between positions exist, and there are enough data to model them. This has the potential advantage that it can take correlations between different positions in the binding motif into account. BIMAS: The BIMAS method was developed by Parker et al., (1994) . The method is based on coefficient tables deduced from the published literature. For HLA-A2, peptide binding data were combined together to generate a table containing 180 coefficients (20 amino acids x 9 positions), each of which represents the contribution of one particular amino acid residue at a specified position within the peptide (Parker et al., 1994) .
SYFPEITHI:
The SYFPEITHI prediction is based on published motifs (pool sequencing, natural ligands) and takes into consideration the amino acids in the anchor and auxiliary anchor positions, as well as other frequent amino acids. The score is calculated according to the following rules: The amino acids of a certain peptide are given a specific value depending on whether they are anchor, auxiliary anchor or preferred residue. Ideal anchors will be given 10 points, unusual anchors 6-8 points, auxiliary anchors 4-6 and preferred residues 1-4 points. Amino acids that are regarded as having a negative effect on the binding ability are given values between -1 and -3 (Rammensee, 1997; . On the SYFPEITHI web site predictions can be made for 5 different MHC II alleles in addition to a number of Class I alleles.
PREDEPP:
In this method the peptide structure in the MHC groove is used as a template upon which peptide candidates are threaded, and their compatibility to bind is evaluated by statistical pairwise potentials. This method has the advantage that it does not require experimental testing of peptide binding, and can thus be used for alleles where only limited data are available (SchuelerFurman et al., 2000) .
Epipredict: Method using synthetic combinatorial peptide libraries to describe peptide-HLA class II interaction in a quantitative way. The binding contribution of every amino acid side chain in a class II-ligand is described by allele-specific two-dimensional databases (Jung et al., 2001) .
Predict:
The Predict method use neural networks to predict Class I, II and TAP binding (Yu et al., 2002) .
Propred:
The Propred method (Singh, 2001 ) is based on the matrices published by Sturniolo (1999) , and is an implementation and extension of the TEPITOPE program. (Hammer, 1995; Raddrizzani, 2000) ). Besides differences that can be attributed to round off errors we have in our tests not seen any differences between the two implementations.
MHCPred: Prediction of binding to 11 different HLA class I alleles using a three-dimensional quantitative structure-activity relationship method (Doytchinova et al., 2002) .
NetMHC: Prediction of HLA-A2 binding using neural networks. This method predicts quantitatively the binding affinity, and is different from methods performing classification only (binding versus non-binding according to a threshold). The method has been trained using quantitative binding data generated
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by the same assay (Buus et al., 2003) , and some predicted binders have been tested for their ability to induce a CTL response in mice and be recognized by CD8+ T-cells from HLA-A2 HIV-1 positive patients (Corbet et al., 2003) . Two well-known prediction methods, TEPITOPE and EpiMatrix (Meister 1995; De Groot, 1997 ) that are not available through the web are listed in Table 3 . TEPI-TOPE is popular since it allows prediction of peptides to many different Class II molecules.
Prediction of proteasomal cleavage sites
The C terminal of MHC class I ligands must most likely be cleaved by the proteasome. The proteasome usually generates precursors of MHC ligands with an extension at the N-termini. These precursors can be trimmed at the Nterminal in the ER. The existence of proteasome cleavage sites within epitopes need not abrogate the immune response for such epitopes. They may, however, reduce the availability, and thereby the immunogenecity of a given peptide (Yewdell, 1999) . The proteasome thus plays an important role in selecting which peptides are presented to CD8+ T cells. In vertebrates stimulation with IFN-γ leads to the replacement of three subunits of the constitutive proteasome to form the so-called immunoproteasome which has a different specificity (reviewed by Uebel, 1999) . Different methods for predicting proteasomal cleavage sites exist on the web (Table 4) . PAProC: Prediction Algorithm for Proteasomal Cleavages is a prediction tool for cleavages by human and yeast proteasomes, based on experimental cleavage data. (Kuttler, 2000; ). An updated version of the PAProC program based on in vitro immunoproteasome cleavage data (Toes, 2001 ) is also in the making according to the PAProC homepage. FRAGPREDICT comprises two different algorithms. One that aims at predicting potential proteasomal cleavage, based on a statistical analysis of cleavagedetermining amino acid motifs present around the scissile bond (Holzhütter et al., 1999 (Holzhütter et al., , 2000 . The second algorithm, which uses the results of the cleavage site analysis as an input, provides predictions of major proteolytic fragments. NetChop: (Kesmir, 2002 ) is a method based on neural networks that have been trained on different data sets. C Kesmir suggests to use the C-term 2.0 network which was trained on C-terminal cleavage sites of 1,110 publicly available MHC class I ligands for predicting the boundaries of CTL. The specificity of this network may resemble the specificity of the immunoproteasome.
Margalits group have also recently made their proteasomal cleavage site propensities (Altuvia and Margalit, 2000) available on the net (bioinfo.md. huji.ac.il/marg/cleavage/index.html).
Combined predictions
A number of sites providing combined predictions have been developed recently. The MAPPP server (Table 2 ) allows the user to make an open reading frame (ORF) search combined with MHC binding and proteasomal cleavage site predictions, and Raghava have a prediction server (www.imtech.res.in/raghava /propred1/index.html) which implements matrices for 47 MHC Class-I alleles and proteasomal and immunoproteasomal models. The NetMHC server allows combination of HLA-A2 and NetChop predictions.
MHC sequence databases
A number of databases containing sequences of proteins of immunological interest exist on the web (Table 5) . MHCDB: "Registered users only" database of MHC sequences. This is an ACeDB-style database holding the Human Major Histocompatibility Database. It is largely superseded by 6ace which is ACeDB-style database of human chromosome 6 from the Sanger Centre.
HIG:

Other sites
A number of other databases relevant to immunology and vaccine design are listed in Table 6 . 
